News und Analysen
Wann kommt Silber endlich?
Während der Goldpreis es kürzlich auf ein 3-Monatshoch geschafft und seit dem Jahrestief fast 7% zugelegt hat, dümpelt Silber seit Wochen vor sich hin. Zwar beträgt der Abstand vom Jahrestiefs bis....
Whom Would the Market Foolery Guys Tap As Business Leader of 2017?
In this segment of the Market Foolery podcast, host Chris Hill chats with Stock Advisor Canada's Taylor Muckerman about whom he'd hand the nonexistent award for Market Foolery CEO of the Year to:....
Why BlackBerry Ltd. Stock Popped Today
Shares of BlackBerry Ltd. (NYSE: BB) were up 9.9% as of 1:30 p.m. EST Wednesday after the enterprise software company announced better-than-expected quarterly results.For its third quarter of....
Why BlackBerry Is a Buy Heading Into Q3 Earnings
BlackBerry's (NYSE: BB) impressive transformation from a seller of smartphones and tablets into a provider of cybersecurity software and services has boosted investor confidence in the stock. The....
Billionaire George Soros Is Betting Big Against These 2 Pharma Stocks
Controversial billionaire George Soros may no longer be actively managing his namesake fund, Soros Fund Management, but the fund's quarterly activity remains a focal point for investors. The Soros....
If You're in Your 60s, Consider Buying These 2 Stocks
If you're in your 60s, you've spent most of your adult life focused on building your nest egg. Now, however, things are changing and you're going to need to shift to using your portfolio to....
2 Silver Mining Stocks to Consider Buying Now -- and 1 to Avoid
Silver mining stocks failed to shine in 2017. Low silver prices proved to be a major growth hurdle -- unlike gold's double-digit rally, silver's gains are only about 3.3% so far this year --....
Why Sanderson Farms, Valeant Pharmaceuticals International, and Criteo Slumped Today
Wall Street finally gave up some ground on Thursday, as the Dow Jones Industrials finished down more than 75 points. Major benchmarks generally posted modest losses of half a percent or less as....
Here's What's Behind Valeant Pharmaceuticals' 13% Drop
Shares of Valeant Pharmaceuticals (NYSE: VRX), the embattled drugmaker that's primarily grown through price hikes and acquisitions this decade, tumbled as much as 13% on Thursday after receiving a....
What's Behind Valeant Pharmaceuticals Inc.'s 11% Move Higher?
Shares of Valeant Pharmaceuticals (NYSE: VRX), the embattled drugmaker that's predominantly grown through acquisitions and drug-price increases over the years, surged as much as 11% by 3 p.m. EST....
The Undeniable Reason Behind Valeant Pharmaceuticals Inc.'s 43% Rally in November
Shares of Valeant Pharmaceuticals (NYSE: VRX), an embattled drugmaker that had primarily grown by acquisitions and drug-price hikes in recent years, galloped higher by 43% in November, according....
2 Top Gold Mining Stocks to Buy Now -- and 1 to Avoid
Investors in gold mining stocks usually expect them to perform in line with gold prices. That, however, is hardly the case and gold stocks may fail to perform even in a high price environment,....
Is Yamana Gold a Buy?
Time to grab the pickaxes and mine the market for the best gold opportunities. On today's docket is Yamana Gold (NYSE: AUY). Headquartered in Canada, the company has one gold-producing mine in....
Alamos Gold stiehlt Barrick Gold die Show!
Der Goldminensektor zusammen mit Gold und Silber kommt seit Wochen kaum vom Fleck. Der HUI-Index bringt es im November bisher auf einen Zugewinn von 2,25 %. Das Marktschwergewicht Barrick Gold....
3 Safe Stocks to Buy Right Now
There are two overarching reasons to be concerned about the stock market right now: Stock valuations are alarmingly high, yet volatility is eerily low. When this has been the case in the past,....
Is Valeant Turning Things Around?
Valeant Pharmaceuticals (NYSE: VRX) is notorious for its drug price gouging scandal a few years ago, an incident that caused the stock to tank and public opinion of the company plummeting to hit....
Shares of Ritchie Bros. Tumble 9% After Disappointing 3rd-Quarter Earnings
Shares of Ritchie Bros Auctioneers, Inc. (NYSE: RBA), the world's largest seller of used heavy equipment via its location and online auctions, are tumbling 9% as of 3:20 p.m. EST after the company....
Here's What Causing Pan American Silver Corp. to Lose Its Luster
Shares of Pan American Silver (NASDAQ: PAAS), a precious-metal mining company with assets throughout North and South America, dipped as much as 10% during Thursday's trading session after the....
Stantec Inc (STN) Q3 2017 Earnings Conference Call Transcript
Image source: The Motley Fool.Stantec Inc. (NYSE: STN)Q3 2017 Earnings Conference CallNov. 9, 2017, 9:00 a.m. ETOperatorContinue readingSource: Fool.com
Here's What Overshadowed Valeant Pharmaceuticals in October, Pushing Its Shares Down 18%
Shares of Valeant Pharmaceuticals (NYSE: VRX), an embattled drug developer that's primarily grown through price hikes and acquisitions over the years, tumbled 18% during October, according to data....
Why IAMGOLD Corp (USA) Stock Popped 10% This Morning
Shares of gold miner IAMGOLD (NYSE: IAG) jumped 10.4% in early-morning trading Wednesday, after it reported its operational and financial performance for third-quarter 2017. According to the....
Is the Worst Behind Valeant Pharmaceuticals' Stock?
Valeant Pharmaceuticals' (NYSE: VRX) is knee-deep in a transformation that it hopes will allow it to regain its top-tier status with investors. The company's selling assets and funneling cash flow....
Why Valeant Pharmaceuticals International Stock Is Shooting Higher Today
Valeant Pharmaceuticals International (NYSE: VRX) stock is up by double-digits today on heavy volume as the result of a better-than-expected third-quarter earnings release. Although the company....
Valeant Pharmaceuticals Posts a Huge Third-Quarter Profit -- but There's a Catch
Valeant Pharmaceuticals (NYSE: VRX) CEO Joe Papa has referred to the company in the past as "the turnaround opportunity of a lifetime." A key part of his turnaround strategy has been reducing the....
2 Figures That'll Tell Us if Valeant Pharmaceuticals' Business Is Improving
In recent years, a Valeant Pharmaceuticals (NYSE: VRX) quarterly earnings report was grounds to call out sick from work, bury yourself under the blankets, and pray you'd still have money left when....